Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.65
0.00 (0.03%)
At close: Aug 15, 2025, 3:59 PM
0.67
2.31%
After-hours: Aug 15, 2025, 07:58 PM EDT

Adicet Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.51M 6.51M 6.51M 12.89M 12.89M 12.89M 12.89M -24.99M -24.99M -24.99M n/a 30.46M 33.89M 38.7M 9.73M 9.67M 9.27M 11.92M
Cost of Revenue
4.87M 4.87M 4.84M 6.53M 7.29M 7.97M 8.14M 8.23M 7.05M 5.83M 5.01M 2.68M 1.51M 445K -552K n/a n/a n/a
Gross Profit
-1.62M -1.62M -1.59M 6.36M 5.6M 4.92M 4.76M -33.22M -32.04M -30.82M -5.01M 27.78M 32.38M 38.26M 10.28M 9.67M 9.27M 11.92M
Operating Income
-126.17M -126.63M -127.62M -128.44M -147.55M -149.59M -152.04M -152.04M -122.76M -110.58M -72.55M -56.53M -47.25M -35.37M -61.43M -55.24M -55.19M -52.99M
Interest Income
7.88M 9.48M 10.71M 10.82M 10.62M 10.23M 9.98M 9.98M 8.68M 6.39M 3.76M 1.62M 398K 82K 91K 135K 284K 504K
Pretax Income
-118.64M -117.32M -117.12M -117.88M -137.29M -139.79M -142.66M -143.04M -115.16M -105.29M -69.79M -55.74M -47.75M -36.14M -62.12M -55.4M -56.17M -53.7M
Net Income
-118.64M -117.32M -117.12M -117.88M -137.29M -139.79M -141.4M -140.02M -111.14M -101.11M -66.86M -54.57M -47.58M -36.06M -62M -55.14M -55.91M -53.51M
Selling & General & Admin
25.41M 28.39M 26.64M 24.29M 24.02M 23.6M 24.84M 26.28M 26.06M 26.06M 26.3M 26.1M 24.89M 23.39M 22.22M 20.94M 23.47M 25.87M
Research & Development
100.76M 98.24M 99.32M 100.81M 100.72M 103.19M 106.04M 106.3M 96.7M 84.52M 71.25M 60.89M 56.24M 50.68M 48.94M 43.97M 40.98M 39.04M
Other Expenses
n/a n/a n/a 1.69M 21.15M 21.03M 20.82M 18.67M -1.01M -1.02M -753K -584K -367K -291K -360K -66K -66K -24K
Operating Expenses
126.17M 126.63M 125.97M 126.79M 145.9M 147.94M 152.04M 152.04M 122.76M 110.58M 97.61M 87.05M 81.2M 74.14M 71.16M 64.91M 64.46M 64.91M
Interest Expense
2K 2K 4K 3K 3K 7K 24K 50K 67K 81K 80K 79K 111K 144K 176K 201K 201K 184K
Selling & Marketing Expenses
n/a n/a -1.65M -3.34M -3.34M -3.34M -1.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
126.17M 126.63M 127.62M 128.44M 147.55M 149.59M 152.04M 152.04M 122.76M 110.58M 97.61M 87.05M 81.2M 74.14M 71.16M 64.91M 64.46M 64.91M
Income Tax Expense
n/a n/a n/a n/a -141K -261K -1.51M -3.29M -4.13M -4.18M -2.93M -1.17M -169K -77K -125K -253K -261K -183K
Shares Outstanding (Basic)
91.09M 91.07M 87.87M 90.85M 90.63M 79.07M 43.04M 42.98M 42.96M 42.89M 41.65M 41.64M 40.08M 46.18M 33.91M 31.88M 31.82M 26M
Shares Outstanding (Diluted)
91.09M 91.07M 87.87M 90.85M 90.63M 79.07M 43.04M 42.98M 42.96M 42.96M 41.65M 41.64M 40.08M 45.96M 33.91M 31.88M 31.82M 26.1M
EPS (Basic)
-1.31 -1.3 -1.34 -1.71 -2.53 -2.95 -3.29 -3.27 -2.61 -2.42 -1.61 -1.41 -1.35 -1.13 -2.07 -2.06 -2.42 -2.54
EPS (Diluted)
-1.31 -1.3 -1.34 -1.71 -2.53 -2.95 -3.29 -3.27 -2.61 -2.42 -1.63 -1.43 -1.37 -1.15 -2.07 -2.06 -2.42 -2.54
EBITDA
-118.27M -114.17M -110.65M -111.35M -130M -131.81M -134.5M -134.77M -108.04M -99.38M -64.7M -51.74M -44.49M -33.46M -60.08M -52.98M -53.84M -51.74M
EBIT
-118.63M -117.32M -117.12M -117.88M -137.29M -139.79M -142.63M -142.99M -115.09M -105.21M -69.71M -55.66M -47.63M -35.99M -61.95M -55.2M -55.97M -53.72M
Depreciation & Amortization
4.89M 6.5M 6.47M 6.53M 7.29M 7.97M 8.14M 8.23M 7.05M 5.83M 5.01M 3.92M 3.97M 4.05M 4.07M 3.69M 2.76M 1.93M